Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated June 10th, 2021

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
How Do Doctors Determine Which Multiple Myeloma Patients Receive CAR T-Cell Therapy?
NOW
PLAYING
When is a Stem Cell Transplant the Best Option for a Multiple Myeloma Patient?
NOW
PLAYING
Multiple Myeloma — Which Drugs Are Best for Induction Chemotherapy?
NOW
PLAYING
What Is a Stem Cell Transplant for Multiple Myeloma?
NOW
PLAYING
11-Year-Old Boy Will Finally Spend Christmas Home After Two Years of Treatment for Leukemia
NOW
PLAYING
Pelé Hospitalized For Chemo Treatment In Colon Cancer Battle

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.